Cancer of the Ovary

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

1989 • 6,734 citations

Bone Marrow Transplant

1990 • 2,745 citations

A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer

1983 • 2,102 citations

Reactivity of a monoclonal antibody with human ovarian carcinoma.

1981 • 1,648 citations

Hypersensitivity reactions from taxol.

1990 • 1,153 citations

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

Cancer statistics, 1993

1993 • 983 citations

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

1991 • 824 citations

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

1987 • 797 citations

GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION

1989 • 776 citations

Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer

1990 • 571 citations

Familial breast-ovarian cancer locus on chromosome 17q12-q23

1991 • 513 citations

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.

1991 • 470 citations

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.

1987 • 385 citations

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.

1992 • 369 citations

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study.

1989 • 328 citations

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

1987 • 307 citations

Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma

1983 • 300 citations

Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer.

1992 • 292 citations

Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.

1991 • 291 citations

A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. A gynecologic oncology group study

1986 • 282 citations

Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer

1991 • 275 citations

Prolonged Disease-Free Survival after Autologous Bone Marrow Transplantation in Patients with Non-Hodgkin's Lymphoma with a Poor Prognosis

1987 • 273 citations

Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer

1992 • 270 citations

MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER

1988 • 245 citations

Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses. Discrimination of benign from malignant disease

1988 • 226 citations

FAMILIAL OVARIAN CANCER: A POPULATION-BASED CASE-CONTROL STUDY1

1988 • 217 citations

Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.

1987 • 217 citations

Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.

1992 • 211 citations

Hypercalcemia and Ectopic Secretion of Parathyroid Hormone by an Ovarian Carcinoma with Rearrangement of the Gene for Parathyroid Hormone

1990 • 196 citations

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

1991 • 194 citations

Meta-analysis of surgery in advanced ovarian carcinoma: Ismaximum cytoreductive surgery an independent determinant of prognosis?

1992 • 194 citations

A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support.

1989 • 190 citations

Predictive value of CA 125 antigen levels in second-look procedures for ovarian cancer

1985 • 181 citations

Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.

1992 • 181 citations

Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell Lines

1989 • 168 citations

Pooled analysis of 3 european case‐control studies: I. Reproductive factors and risk of epithelial ovarian cancer

1991 • 164 citations

Nongenital cancers metastatic to the ovary

1992 • 161 citations

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

1992 • 161 citations

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

1992 • 159 citations

The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma.

1988 • 154 citations

High-dose carboplatin in refractory ovarian cancer patients.

1987 • 151 citations

Second-look operations in ovarian cancer

1980 • 149 citations

Krukenberg tumors of the ovary. A clinicopathologic analysis of 27 cases

1982 • 146 citations

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma.

1986 • 139 citations

Transvaginal sonography as a screening method for ovarian cancer a report of the first 1000 cases screened

1990 • 135 citations

Advanced Ovarian Cancer: Long-Term Results of Treatment with Intensive Cisplatin-Based Chemotherapy of Brief Duration

1988 • 132 citations

Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.

1989 • 128 citations

Ultrasound screening for familial ovarian cancer

1991 • 126 citations

CA 125 Serum Levels Correlated With Second-Look Operations Among Ovarian Cancer Patients

1986 • 126 citations

Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.

1991 • 124 citations

Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.

1992 • 124 citations

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.

1990 • 122 citations

Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma

1989 • 119 citations

The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer

1986 • 112 citations

Epidermal growth factor receptor expression in normal ovarian epithelium and ovarian cancer

1991 • 112 citations

Microscopic disease at second-look laparotomy in advanced ovarian cancer

1985 • 109 citations

Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.

1989 • 88 citations

Surgery for common epithelial tumors of the ovary

1981 • 86 citations

Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.

1993 • 83 citations

Hexamethylmelamine as a single second-line agent in ovarian cancer

1990 • 78 citations

High-dose platinum consisting of combined carboplatin and cisplatin in previously untreated ovarian cancer patients with residual disease.

1989 • 71 citations

Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.

1988 • 62 citations

Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma.

1988 • 58 citations

Characteristics of patients with small-volume residual ovarian cancer unresponsive to cisplatin-based ip chemotherapy: Lessons learned from a gynecologic oncology group phase II trial of ip cisplatin and recombinant α-interferon

1992 • 56 citations

High-dose chemotherapy with autologous bone marrow transplantation in patients with refractory ovarian cancer

1989 • 55 citations

The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma

1992 • 55 citations

High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer

1990 • 52 citations

Advanced epithelial ovarian cancer: salvage whole abdominal irradiation for patients with recurrent or persistent disease after combination chemotherapy.

1988 • 47 citations

A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinoma.

1991 • 44 citations

Salvage therapy with whole-abdominal irradiation in patients with advanced carcinoma of the ovary previously treated by combination chemotherapy

1986 • 44 citations

Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy

1992 • 41 citations

High-dose melphalan and autologous bone marrow support for treatment of ovarian carcinoma with positive second-look operation

1989 • 41 citations

Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease.

1990 • 36 citations

Dose-intensive induction therapy with cyclophosphamide, cisplatin, and consolidative abdominal radiation in advanced-stage epithelial ovarian cancer.

1992 • 36 citations

A comparison of findings at second-look laparotomy with preoperative computed tomography in patients with ovarian cancer

1988 • 30 citations

Phase I trial of thiotepa in combination with recombinant human granulocyte-macrophage colony-stimulating factor.

1992 • 29 citations

Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer

1984 • 26 citations

Paraneoplastic hypercalcaemia in ovarian carcinoma.

1984 • 26 citations

High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma.

1990 • 24 citations

Twice-daily, split-course abdominopelvic radiation therapy after chemotherapy and positive second-look laparotomy for epithelial ovarian carcinoma

1991 • 24 citations

Phase II trial of VP-16-213 in advanced ovarian carcinoma

1985 • 24 citations

Ovarian adenocarcinoma presenting with the sign of Leser-Trélat

1986 • 20 citations

Endometrioid carcinoma of the ovary presenting with an enlarged inguinal lymph node without evidence of abdominal carcinomatosis

1992 • 20 citations

Preservation of ovarian function and reproductive ability in patients with malignant ovarian tumors

1988 • 19 citations

Ovarian carcinoma preceded by cerebral metastasis: Review of the literature

1992 • 18 citations

Hereditary Ovarian Carcinoma

1992 • 14 citations

Case 34-1989

1989 • 3 citations